List view / Grid view
11 June 2015 | By Victoria White
Researchers have identified a naturally occurring variant of the human prion protein that produces resistance to prion diseases such as CJD...
11 June 2015 | By Victoria White
BioNTech has launched MammaTyper, a molecular diagnostic test for breast cancer, for universal use in pathology laboratories in Europe...
11 June 2015 | By Victoria White
The European Society of Clinical Microbiology and Infectious Diseases has launched a new study group: the Forensic and Postmortem Microbiology Study Group...
11 June 2015 | By Victoria White
LDC and Johnson & Johnson Innovation will collaborate to identify and accelerate innovative drug candidates for diseases with high unmet medical needs...
11 June 2015 | By Victoria White
The results of a study presented at EULAR 2015 showed that people with systemic sclerosis have a unique bacterial signature in their colon.
11 June 2015 | By Victoria White
Countering previously held beliefs, researchers have discovered that inhibiting TLR4 may not be a wise treatment strategy in all cancers...
11 June 2015 | By Victoria White
ModiQuest has discovered the cellular mechanism of action of its tACPA for the treatment of rheumatoid arthritis (RA) and other diseases...
10 June 2015 | By Victoria White
Isarna Therapeutics has announced that the Food and Drug Administration (FDA) has granted orphan drug designation for ISTH0036...
10 June 2015 | By Victoria White
Selecta Biosciences has initiated a Phase 1 study to assess the safety, pharmacodynamic profile, and immunogenicity of pegsiticase, a component of SEL-212...
10 June 2015 | By Victoria White
Researchers have discovered that certain microRNAs are also asymmetrically distributed within cells and may contribute as cell fate determinants...
10 June 2015 | By Victoria White
A previously unknown link between the immune system and the death of motor neurons in amyotrophic lateral sclerosis has been discovered by scientists...
10 June 2015 | By Victoria White
MRC Technology and Peptinnovate are collaborating to assess the therapeutic potential in bone diseases of peptides derived from Mycobacterium tuberculosis...
10 June 2015 | By Victoria White
Lycera has formed of an exclusive global collaboration with Celgene to take forward Lycera's proprietary pipeline for cancer and immune-mediated diseases...
9 June 2015 | By Victoria White
Researchers have identified the molecular docking site that is responsible for C. difficile toxins being able to bind to a receptor...
9 June 2015 | By Victoria White
Scientists have discovered that a toxin secreted by Vibrio vulnificus has potential to prevent the growth of tumours by cutting the protein Ras...
